Dietary treatment of phenylketonuria: The effect of phenylalanine on reaction time

Journal of Inherited Metabolic Disease

Volumn 34, Issue 2, 2011, Pages 449-454

  Dawson, Charlotte ^a   Murphy, Elaine ^a   Maritz, Charlé ^a   Chan, Heidi ^a   Ellerton, Charlotte ^a   Carpenter, R H S ^b   Lachmann, Robin H ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MATERNAL NUTRITION; OUTPATIENT; PATIENT MONITORING; PHENYLKETONURIA; PROTEIN RESTRICTION; RESPONSE TIME; SACCADIC EYE MOVEMENT;

ADULT; CASE-CONTROL STUDIES; COGNITION; DIET; FEMALE; HUMANS; MALE; PHENYLALANINE; PHENYLKETONURIA, MATERNAL; PHENYLKETONURIAS; PRECONCEPTION CARE; PREGNANCY; QUALITY OF LIFE; REACTION TIME; SACCADES;

EID: 79955689670     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9276-2     Document Type: Article

References (23)

1. Albrecht J, Garbade SF, Burgard P (2009) Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis. Neurosci Biobehav Rev 33:414-421
2. Ali FR, Michell AW, Barker RA, Carpenter RHS (2006) The use of quantitative oculometry in the assessment of Huntington's disease. Exp Brain Res 169:237-245 (Pubitemid 43221149)
3. Brenton DP, Pietz J (2000) Adult care in phenylketonuria and hyperphenylalaninaemia: the relevance of neurological abnormalities. Eur J Pediatr 159(Suppl 2):S114-120
4. Burgard P (2000) Development of intelligence in early treated phenylketonuria. Eur J Pediatr 159(Suppl 2):S74-79
5. Carpenter RH (2000) The neural control of looking. Curr Biol 10: R291-293
6. Carpenter RHS (2005) Visual pursuit: an instructive area of cortex. Curr Biol 15:R638-640
7. Carpenter RH, Williams ML (1995) Neural computation of log likelihood in control of saccadic eye movements. Nature 377:59-62
8. Christ SE, Huijbregts SC, de Sonneville LM, White DA (2010) Executive function in early-treated phenylketonuria: profile and underlying mechanisms. Mol Genet Metab 99:S22-S32
9. Cleary MA, Walter JH, Wraith JE, White F, Tyler K, Jenkins JP (1995) Magnetic resonance imaging in phenylketonuria: reversal of cerebral white matter change. J Pediatr 127:251-255
10. de Groot MJ, Hoeksma M, Blau N, Reijngoud DJ, van Spronsen FJ (2010) Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses. Mol Genet Metab 99(Suppl 1):S86-89
11. Gassió R, Campistol J, Vilaseca MA, Lambruschini N, Cambra FJ, Fusté E (2003) Do adult patients with phenylketonuria improve their quality of life after introduction/resumption of a phenylalanine-restricted diet? Acta Paediatr 92:1474-1478
12. Gentile JK, Ten Hoedt AE, Bosch AM (2010) Psychosocial aspects of PKU: hidden disabilities - a review. Mol Genet Metab 99(Suppl 1):S64-67
13. Klein C, Foerster F, Hartnegg K, Fischer B (2005) Lifespan development of pro- and anti-saccades: multiple regression models for point estimates. Brain Res Dev Brain Res 160:113-123 (Pubitemid 41735118)
14. Levy HL, Ghavami M (1996) Maternal phenylketonuria: a metabolic teratogen. Teratology 53:176-184 (Pubitemid 26190890)
15. Maillot F, Lilburn M, Baudin J, Morley DW, Lee PJ (2008) Factors influencing outcomes in the offspring of mothers with phenylketonuria during pregnancy: the importance of variation in maternal blood phenylalanine. Am J Clin Nutr 88:700-705
16. Ober JK, Przedpelska-Ober E, Gryncewicz W et al (2003) Hand-held system for ambulatory measurement of saccadic durations of neurological patients. In: Gajda J (ed) Modelling and measurement in medicine. Komitet Biocybernityki i Inzyneierii Biomedycznej PAN, Warsaw, pp 187-198
17. Pearson BC, Armitage KR, Horner CWM, Carpenter RHS (2007) Saccadometry: the possible application of latency distribution measurement for monitoring concussion. Br J Sports Med 41:610-612 (Pubitemid 47435083)
18. Pietz J, Kreis R, Schmidt H, Meyding-Lamadé UK, Rupp A, Boesch C (1996) Phenylketonuria: findings at MR imaging and localized in vivo H-1 MR spectroscopy of the brain in patients with early treatment. Radiology 201:413-420 (Pubitemid 26357636)
19. Pietz J, Kreis R, Rupp A, Mayatepek E, Rating D, Boesch C, Bremer HJ (1999) Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria. J Clin Invest 103:1169-1178 (Pubitemid 29207251)
20. Donlon J, Levy H, Scriver CR (2008) Hyperphenylalaninemia: phenylalanine hydroxylase deficiency. In: Valle D, Beaudet AL, Vogelstein B (eds) The metabolic and molecular bases of inherited disease, online. McGraw-Hill, New York
21. van Spronsen FJ, Hoeksma M, Reijngoud D (2009) Brain dysfunction in phenylketonuria: is phenylalanine toxicity the only possible cause? J Inherit Metab Dis 32:46-51
22. Vermathen P, Robert-Tissot L, Pietz J, Lutz T, Boesch C, Kreis R (2007) Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med 58:1145-1156 (Pubitemid 350234201)
23. Walter JH, White FJ, Hall SK, MacDonald A, Rylance G, Boneh A, Francis DE, Shortland GJ, Schmidt M, Vail A (2002) How practical are recommendations for dietary control in phenylketonuria? Lancet 360:55-57